These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32562253)

  • 1. Carrageenan from red algae: an application in the development of inhalable tuberculosis therapy targeting the macrophages.
    Rodrigues S; Cunha L; Rico J; Rosa da Costa AM; Almeida AJ; Faleiro ML; Buttini F; Grenha A
    Drug Deliv Transl Res; 2020 Dec; 10(6):1675-1687. PubMed ID: 32562253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spray-dried fucoidan microparticles for pulmonary delivery of antitubercular drugs.
    Cunha L; Rosa da Costa AM; Lourenço JP; Buttini F; Grenha A
    J Microencapsul; 2018 Jun; 35(4):392-405. PubMed ID: 30112917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhalable Fucoidan Microparticles Combining Two Antitubercular Drugs with Potential Application in Pulmonary Tuberculosis Therapy.
    Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro ML; Buttini F; Grenha A
    Polymers (Basel); 2018 Jun; 10(6):. PubMed ID: 30966670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhalable chitosan microparticles for simultaneous delivery of isoniazid and rifabutin in lung tuberculosis treatment.
    Cunha L; Rodrigues S; Rosa da Costa AM; Faleiro L; Buttini F; Grenha A
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1313-1320. PubMed ID: 30990096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytocompatibility and cellular interactions of chondroitin sulfate microparticles designed for inhaled tuberculosis treatment.
    Rodrigues S; Cunha L; Kollan J; Neumann PR; Rosa da Costa AM; Dailey LA; Grenha A
    Eur J Pharm Biopharm; 2021 Jun; 163():171-178. PubMed ID: 33838263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual antibiotherapy of tuberculosis mediated by inhalable locust bean gum microparticles.
    Rodrigues S; Alves AD; Cavaco JS; Pontes JF; Guerreiro F; Rosa da Costa AM; Buttini F; Grenha A
    Int J Pharm; 2017 Aug; 529(1-2):433-441. PubMed ID: 28669623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhalable Antitubercular Therapy Mediated by Locust Bean Gum Microparticles.
    Alves AD; Cavaco JS; Guerreiro F; Lourenço JP; Rosa da Costa AM; Grenha A
    Molecules; 2016 May; 21(6):. PubMed ID: 27240337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
    Pai RV; Jain RR; Bannalikar AS; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhalable poly(lactic-co-glycolic acid) (PLGA) microparticles encapsulating all-trans-Retinoic acid (ATRA) as a host-directed, adjunctive treatment for Mycobacterium tuberculosis infection.
    O'Connor G; Krishnan N; Fagan-Murphy A; Cassidy J; O'Leary S; Robertson BD; Keane J; O'Sullivan MP; Cryan SA
    Eur J Pharm Biopharm; 2019 Jan; 134():153-165. PubMed ID: 30385419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection.
    Grenha A; Alves AD; Guerreiro F; Pinho J; Simões S; Almeida AJ; Gaspar MM
    Eur J Pharm Biopharm; 2020 Feb; 147():38-44. PubMed ID: 31790800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhalable microparticles containing large payload of anti-tuberculosis drugs.
    Muttil P; Kaur J; Kumar K; Yadav AB; Sharma R; Misra A
    Eur J Pharm Sci; 2007 Oct; 32(2):140-50. PubMed ID: 17681458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalable microparticles containing isoniazid and rifabutin target macrophages and 'stimulate the phagocyte' to achieve high efficacy.
    Yadav AB; Sharma R; Muttil P; Singh AK; Verma RK; Mohan M; Patel SK; Misra A
    Indian J Exp Biol; 2009 Jun; 47(6):469-74. PubMed ID: 19634713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice.
    Verma RK; Kaur J; Kumar K; Yadav AB; Misra A
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3195-201. PubMed ID: 18591268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhalable microparticles containing drug combinations to target alveolar macrophages for treatment of pulmonary tuberculosis.
    Sharma R; Saxena D; Dwivedi AK; Misra A
    Pharm Res; 2001 Oct; 18(10):1405-10. PubMed ID: 11697465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhaled Solid Lipid Microparticles to target alveolar macrophages for tuberculosis.
    Maretti E; Rossi T; Bondi M; Croce MA; Hanuskova M; Leo E; Sacchetti F; Iannuccelli V
    Int J Pharm; 2014 Feb; 462(1-2):74-82. PubMed ID: 24374224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-mediated macrophage targeting-a new inhalation therapy tackling tuberculosis.
    Makled S; Boraie N; Nafee N
    Drug Deliv Transl Res; 2021 Jun; 11(3):1037-1055. PubMed ID: 32617866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoniazid-gelatin conjugate microparticles containing rifampicin for the treatment of tuberculosis.
    Manca ML; Cassano R; Valenti D; Trombino S; Ferrarelli T; Picci N; Fadda AM; Manconi M
    J Pharm Pharmacol; 2013 Sep; 65(9):1302-11. PubMed ID: 23927468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and Preclinical Evaluation of Inhalable Particles Containing Rapamycin and Anti-Tuberculosis Agents for Induction of Autophagy.
    Gupta A; Sharma D; Meena J; Pandya S; Sachan M; Kumar S; Singh K; Mitra K; Sharma S; Panda AK; Gupta P; Gupta UD; Misra A
    Pharm Res; 2016 Aug; 33(8):1899-912. PubMed ID: 27095353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhalable Particles for "Pincer Therapeutics" Targeting Nitazoxanide as Bactericidal and Host-Directed Agent to Macrophages in a Mouse Model of Tuberculosis.
    Gupta A; Meena J; Sharma D; Gupta P; Gupta UD; Kumar S; Sharma S; Panda AK; Misra A
    Mol Pharm; 2016 Sep; 13(9):3247-55. PubMed ID: 27463245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering of konjac glucomannan into respirable microparticles for delivery of antitubercular drugs.
    Guerreiro F; Swedrowska M; Patel R; Flórez-Fernández N; Torres MD; Rosa da Costa AM; Forbes B; Grenha A
    Int J Pharm; 2021 Jul; 604():120731. PubMed ID: 34029661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.